The company’s patented hemodialysis device selectively captures, treats, or removes target pathogens e.g. cells, virus, toxins, and antibodies. This is unlike other hemodialysis devices that focus on dialysis with limited innovative treatments. This device combines cutting edge biotech innovations with hemodialysis. The device uses antibody/ligand mediated target capture. Hospital and dialysis centers can use the device to treat other diseases such as metastatic cancer, autoimmune disease, viral infections, and sepsis.